Progyny [PGNY] vs Elevance Health [ELV] Detailed Stock Comparison

Progyny Inc.

NASDAQ
Loading...

Elevance Health Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Progyny Inc. wins in 6 metrics, Elevance Health Inc. wins in 13 metrics, with 0 ties. Elevance Health Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Progyny Inc. Elevance Health Inc. Better
P/E Ratio (TTM) 27.18 13.19 Elevance Health Inc.
Price-to-Book Ratio 2.83 1.67 Elevance Health Inc.
Debt-to-Equity Ratio 5.37 74.39 Progyny Inc.
PEG Ratio 1.09 0.38 Elevance Health Inc.
EV/EBITDA 11.90 7.65 Elevance Health Inc.
Profit Margin (TTM) 4.54% 2.84% Progyny Inc.
Operating Margin (TTM) 7.20% 1.54% Progyny Inc.
EBITDA Margin (TTM) 7.20% 1.54% Progyny Inc.
Return on Equity 12.48% 13.25% Elevance Health Inc.
Return on Assets (TTM) 8.61% 4.35% Progyny Inc.
Free Cash Flow (TTM) $191.78M $3.17B Elevance Health Inc.
Dividend Yield N/A 2.36% N/A
1-Year Return 26.63% 5.08% Progyny Inc.
Price-to-Sales Ratio (TTM) 1.12 0.37 Elevance Health Inc.
Enterprise Value $1.16B $69.19B Elevance Health Inc.
EV/Revenue Ratio 0.90 0.35 Elevance Health Inc.
Gross Profit Margin (TTM) 24.15% N/A N/A
Revenue per Share (TTM) $15 $889 Elevance Health Inc.
Earnings per Share (Diluted) $0.65 $25.20 Elevance Health Inc.
Beta (Stock Volatility) 0.99 0.50 Elevance Health Inc.
Short % of Float 10.89% 2.02% Elevance Health Inc.

Progyny Inc. vs Elevance Health Inc. Stock Performance Analysis

Loading Price Chart...

PGNY
ELV

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Progyny Inc.1.05%3.82%15.74%54.48%2.16%4.55%
Elevance Health Inc.-0.54%-3.89%2.35%37.60%11.43%13.45%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Progyny Inc.26.63%-31.61%-58.69%67.06%67.06%67.06%
Elevance Health Inc.5.08%-8.83%9.44%205.33%430.00%468.71%

Performance & Financial Health Analysis: Progyny Inc. vs Elevance Health Inc.

MetricPGNYELV
Market Information
Market Cap i$1.45B$76.43B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,317,2181,344,463
90 Day Avg. Volume i1,312,3261,625,618
Last Close$26.91$401.89
52 Week Range$16.10 - $28.75$273.71 - $426.98
% from 52W High-6.40%-5.88%
All-Time High$68.32 (Nov 01, 2021)$567.26 (Sep 02, 2024)
% from All-Time High-60.61%-29.15%
Growth Metrics
Quarterly Revenue Growth0.07%0.10%
Quarterly Earnings Growth0.19%0.31%
Financial Health
Profit Margin (TTM) i0.05%0.03%
Operating Margin (TTM) i0.07%0.02%
Return on Equity (TTM) i0.12%0.13%
Debt to Equity (MRQ) i5.3774.39
Cash & Liquidity
Book Value per Share (MRQ)$6.24$198.81
Cash per Share (MRQ)$3.79$163.64
Operating Cash Flow (TTM) i$210.19M$4.29B
Levered Free Cash Flow (TTM) i$212.50M$3.40B
Dividends
Last 12-Month Dividend Yield iN/A2.36%
Last 12-Month Dividend iN/A$6.85

Valuation & Enterprise Metrics Analysis: Progyny Inc. vs Elevance Health Inc.

MetricPGNY (Apr 24, 2026)ELV (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i27.1813.19
Forward P/E i8.4111.44
PEG Ratio i1.090.38
Price to Sales (TTM) i1.120.37
Price to Book (MRQ) i2.831.67
Market Capitalization
Market Capitalization i$1.45B$76.43B
Enterprise Value i$1.16B$69.19B
Enterprise Value Metrics
Enterprise to Revenue i0.900.35
Enterprise to EBITDA i11.907.65
Risk & Other Metrics
Beta i0.990.50
Book Value per Share (MRQ) i$6.24$198.81

Financial Statements Comparison: Progyny Inc. vs Elevance Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPGNY (2025)ELV (2025)
Revenue/Sales i1.29B199.13B
Cost of Goods Sold i984.18MN/A
COGS % of Revenue i76.4%0.0%
Gross Profit i304.48MN/A
Gross Margin i23.6%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) i85.28MN/A
Operating Margin i6.6%0.0%
EBITDA i90.23MN/A
EBITDA Margin i7.0%0.0%
Pre-Tax Income i95.43M6.71B
Pre-Tax Income % of Revenue i7.4%3.4%
Income Tax i36.91M1.05B
Income Tax % of Revenue i2.9%0.5%
Net Income (Profit) i58.52M5.66B
Profit Margin i4.5%2.8%

Balance Sheet & Liquidity Metrics

MetricPGNY (2025)ELV (2025)
Cash & Equivalents i112.24M9.49B
Total Current Assets i551.78MN/A
Total Current Assets % of Revenue i42.8%0.0%
Total Current Liabilities i202.39MN/A
Total Current Liabilities % of Revenue i15.7%0.0%
Long-Term Debt i24.00M30.80B
Long-Term Debt % of Revenue i1.9%15.5%
Total Shareholders Equity i516.04M44.03B
Retained Earnings i202.83M35.39B
Retained Earnings % of Revenue i15.7%17.8%
Property, Plant & Equipment i24.99MN/A

Cash Flow Statement Comparison

MetricPGNY (2025)ELV (2025)
Operating Cash Flow i201.98M2.15B
Operating Cash Flow % of Revenue i15.7%1.1%
Capital Expenditures i-18.41M-1.12B
Free Cash Flow i191.78M3.17B
FCF Margin i14.9%1.6%
Debt Repayment iN/A-3.87B
Common Stock Repurchase i-81.66M-2.61B

Short Interest & Institutional Ownership Analysis

MetricPGNYELV
Shares Short i6.08M3.97M
Short Ratio i3.781.73
Short % of Float i10.89%2.02%
Shares Outstanding i83.37M220.72M
Float Shares i74.96M220.20M
% Held by Insiders i1.91%0.19%
% Held by Institutions i114.23%94.27%
% Held by Public i-16.14%5.54%

Dividend Analysis & Yield Comparison: Progyny Inc. vs Elevance Health Inc.

MetricPGNYELV
Last 12-Month Dividend iN/A$6.85
Last 12-Month Dividend Yield iN/A2.36%
3-Year Avg Annual Dividend iN/A$6.51
3-Year Avg Dividend Yield iN/A0.40%
3-Year Total Dividends iN/A$19.52
Ex-Dividend DateN/AMar 10, 2026